GoodRx Holdings, Inc. Class A GDRX 深 滬
已收盤 02-06 16:00:00 美东时间
2.44
+0.150
+6.55%
華盛通- 最 高2.47
- 今 開2.29
- 成交量 638.19万股
- 最 低 2.17
- 昨 收 2.29
- 總市值 8.28亿
- 52周最高 5.8099
- 市盈率 靜 58.37
- 換手率 1.88%
- 52周最低 2.10
- 委 比 42.11%
- 總股本 3.39亿
- 歷史最高 64.219
- 量 比 1.21
- 振 幅 13.10%
- 歷史最低 2.10
- 每 手 1
- 風險率 0.82%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多GoodRx becomes pricing source for Pfizer and other drugmakers on TrumpRx
GoodRx (GDRX) announced that it has become a major integration partner for Pfizer (PFE) and other pharmaceutical companies, which offer discounts on TrumpRx, a newly launched government website listin...
02-06 23:47
特朗普开了一个“低价药”网站，美国人买药贵的老问题有解了？
美国东部时间 2026 年 2 月 5 日晚 7 点，唐纳德·特朗普在白宫举办了一场颇具仪式感的活动，宣布 TrumpRx.gov 正式上线。 这个由政府运营的...
02-06 12:18
特朗普推出折扣处方药网站TrumpRx，作为降低美国药价的核心举措
美国总统特朗普周四宣布推出TrumpRx.gov网站，该平台旨在为消费者提供折扣处方药，是其降低美国药品价格努力的核心举措。 特朗普在白宫活动上宣布该网...
02-06 11:12
60 Degrees Pharmaceuticals Partners With GoodRx To Expand Access To ARAKODA
GoodRx to offer prescription savings of up to 30% for ARAKODA® (tafenoquine)Collaboration designed to lower patient out-of-pocket costs and expand the reach of Company's marketing strategyPartnership will
02-02 21:10
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
60 Degrees Pharmaceuticals partners with GoodRx to offer up to 30% off ARAKODA, a once-weekly malaria prevention. The collaboration aims to reduce patient costs and expand access nationwide at over 70,000 pharmacies, benefiting travelers to malaria-endemic regions. ARAKODA is the only FDA-approved broad-spectrum once-weekly malaria prophylaxis. The discount will be available starting February 2, 2026.
02-02 13:01
美股大行评级 | 潜在涨幅258.31%！Tempest Therapeutics获HC Wainwright上调评级至"买入"，目标价11美元
今日重点评级关注：HC Wainwright & Co.：上调Tempest Therapeutics评级至"买入"，目标价11美元；Guggenheim：维持Sportradar Gr"买入"评级，目标价从34美元升至35美元
01-23 19:46
Demystifying GoodRx Holdings: Insights From 8 Analyst Reviews
Analysts' ratings for GoodRx Holdings (NASDAQ:GDRX) over the last quarter vary ...
01-23 06:01
Jefferies Downgrades GoodRx Holdings to Hold, Lowers Price Target to $2.75
Jefferies analyst Glen Santangelo downgrades GoodRx Holdings (NASDAQ:GDRX) from Buy to Hold and lowers the price target from $5.25 to $2.75.
01-22 21:12
U.S. RESEARCH ROUNDUP-Cencora, Crocs, Teledyne Technologies
U.S. RESEARCH ROUNDUP-Cencora, Crocs, Teledyne Technologies Jan 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cencora, Crocs and Teledyne Technologies, on Thursday. HIGHLIGHTS * Cencora COR.N : Jefferies raises to b
01-22 15:17
美股大行评级 | 瑞穗上调英伟达、谷歌、美光科技、SanDisk多家科技股目标价；中金首予诺和诺德"跑赢大市"评级，目标价73.5美元
今日重点评级关注：Needham：维持Cartesian Therapeutics"买入"评级，目标价从40美元升至42美元；Piper Sandler：维持Acrivon Therapeutics"超配"评级，目标价从6美元升至8美元
01-12 14:09
